Stockscreener 앱 받기
48.09
2.12%
1.00
전일 마감가:
$47.09
열려 있는:
$46.95
하루 거래량:
442.34K
Relative Volume:
1.06
시가총액:
$1.67B
수익:
-
순이익/손실:
$-91.00M
주가수익비율:
-13.10
EPS:
-3.67
순현금흐름:
$-74.38M
1주 성능:
+8.70%
1개월 성능:
+17.29%
6개월 성능:
-19.12%
1년 성능:
+50.66%
1일 변동 폭
$46.51
$48.20
1주일 범위
$44.80
$48.20
52주 변동 폭
$30.65
$68.73
Disc Medicine Inc Stock (IRON) Company Profile
명칭
Disc Medicine Inc
전화
(617) 674-9274
주소
321 ARSENAL STREET, SUITE 101, WATERTOWN
IRON을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
48.09 | 1.53B | 0 | -91.00M | -74.38M | -3.67 |
|
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-27 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | 개시 | Jefferies | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-08-22 | 개시 | Wells Fargo | Overweight |
| 2024-04-01 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | 개시 | H.C. Wainwright | Buy |
| 2023-05-17 | 개시 | Raymond James | Outperform |
| 2023-04-28 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-04-21 | 개시 | Stifel | Buy |
| 2023-04-20 | 개시 | Morgan Stanley | Overweight |
| 2023-03-23 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-28 | 개시 | SVB Securities | Outperform |
모두보기
Disc Medicine Inc 주식(IRON)의 최신 뉴스
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Northern Trust Corp - Defense World
Commit To Buy Disc Medicine At $35, Earn 14.1% Annualized Using Options - Nasdaq
Disc Medicine Announces Multiple Presentations Across Portfolio - GuruFocus
Disc Medicine, Inc. to Present Key Data from Hematology Portfolio at EHA 2025 Congress - Nasdaq
Disc Medicine Announces Multiple Presentations Across - GlobeNewswire
Disc Medicine Reveals First Disease-Modifying EPP Treatment Data Among 6 Clinical Updates at EHA 2025 - Stock Titan
BMO Capital Markets Forecasts Strong Price Appreciation for Disc Medicine (NASDAQ:IRON) Stock - Defense World
Disc Medicine to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference - The Manila Times
Tower Research Capital LLC TRC Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
How To Trade (IRON) - news.stocktradersdaily.com
Disc Medicine (IRON) Price Target Raised by BMO Capital | IRON S - GuruFocus
Promising Outlook for Disc Medicine’s DISC-0974 in Anemia Treatment Justifies Buy Rating - TipRanks
BMO Capital Boosts Price Target for Disc Medicine (IRON) to $120 - GuruFocus
Cantor Fitzgerald Comments on Disc Medicine FY2025 Earnings - Defense World
Q2 EPS Estimates for Disc Medicine Cut by Leerink Partnrs - Defense World
Insider Sellers Might Regret Selling Disc Medicine Shares at a Lower Price Than Current Market Value - simplywall.st
Disc Medicine, Inc. (NASDAQ:IRON) Shares Acquired by Dimensional Fund Advisors LP - Defense World
Wedbush Issues Negative Forecast for Disc Medicine Earnings - Defense World
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Disc Medicine Reports Strong Q1 2025 Progress - TipRanks
Here's Why We're Not Too Worried About Disc Medicine's (NASDAQ:IRON) Cash Burn Situation - Yahoo Finance
Decoding Disc Medicine Inc (IRON): A Strategic SWOT Insight - GuruFocus
Market Resilience: Disc Medicine Inc (IRON) Finishes Weak at 42.58, Down -12.40 - DWinneX
Disc Medicine Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Disc Medicine reports Q1 EPS ($1.02), consensus ($1.07) - TipRanks
Disc Medicine, Inc. SEC 10-Q Report - TradingView
Disc Medicine Inc (IRON) Reports Q1 2025 EPS of -$1.02, Aligns with Estimates; Strong Cash Position of $694.7 Million - GuruFocus
Disc's Bitopertin Program Advances with APOLLO Trial Launch | IRON Stock News - GuruFocus
Disc Medicine, Inc. Reports Q1 2025 Financial Results and Updates on Bitopertin and Pipeline Programs - Nasdaq
Invesco Ltd. Increases Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
(IRON) On The My Stocks Page - news.stocktradersdaily.com
Wells Fargo & Company MN Grows Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine to Host Webinar with Key Opinion Leaders on Anemia of Myelofibrosis (MF) - The Manila Times
Leading Cancer Centers Join Forces to Review Breakthrough Myelofibrosis Anemia Treatment Data - Stock Titan
JPMorgan Chase & Co. Purchases 44,762 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Renaissance Technologies LLC Makes New $5.48 Million Investment in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
When (IRON) Moves Investors should Listen - news.stocktradersdaily.com
Disc Medicine, Inc. (NASDAQ:IRON) Shares Sold by Geode Capital Management LLC - Defense World
New GlyT-1 inhibitors disclosed in Disc Medicine patent - BioWorld MedTech
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Rating of “Buy” by Brokerages - Defense World
Disc Medicine price target raised to $132 from $99 at Cantor Fitzgerald - MSN
Vanguard Group Inc. Has $67.73 Million Stock Holdings in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine: Forging Ahead In Hematology (NASDAQ:IRON) - Seeking Alpha
3,700 Shares in Disc Medicine, Inc. (NASDAQ:IRON) Acquired by KLP Kapitalforvaltning AS - Defense World
Corebridge Financial Inc. Has $622,000 Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine, Inc.'s (NASDAQ:IRON) institutional investors lost 21% over the past week but have profited from longer-term gains - simplywall.st
Teacher Retirement System of Texas Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine is Now Oversold (IRON) - Nasdaq
Swiss National Bank Sells 2,600 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc medicine director Ashiya Mona sells shares worth $310,483 By Investing.com - Investing.com Canada
Orbimed advisors sells $310,483 in disc medicine stock By Investing.com - Investing.com Canada
Disc Medicine Inc (IRON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.54%
7.58%
자본화:
|
볼륨(24시간):